Sanibel Captiva Trust Company’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$766K Sell
17,941
-2,794
-13% -$152K 0.02% 280
2026
Q1
$1.3M Buy
20,735
+5,818
+39% +$465K 0.04% 219
2025
Q4
$1.42M Buy
14,917
+2,928
+24% +$287K 0.04% 205
2025
Q3
$1.17M Buy
11,989
+1,790
+18% +$185K 0.03% 219
2025
Q2
$1.1M Buy
10,199
+6,246
+158% +$632K 0.03% 220
2025
Q1
$399K Buy
+3,953
New +$398K 0.01% 301

Other funds holding BSX

Sanibel Captiva Trust Company's BSX Position: Q2 2026 in Review

Sanibel Captiva Trust Company reduced its Boston Scientific (BSX) stake by 13% in Q2 2026, selling an estimated $152K and leaving 17,941 shares worth $766K. The position accounts for 0.02% of the portfolio, ranked #280.

Sanibel Captiva Trust Company first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.42M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Sanibel Captiva Trust Company held 17,941 shares of Boston Scientific worth $766K as of Q2 2026.
  • Sanibel Captiva Trust Company sold 2,794 Boston Scientific shares in Q2 2026, an estimated $152K.
  • Boston Scientific made up 0.02% of Sanibel Captiva Trust Company's portfolio in Q2 2026, its #280 holding.
  • Sanibel Captiva Trust Company first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • Sanibel Captiva Trust Company's Boston Scientific position peaked at $1.42M in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q2 2026, filed 27 Jul 2026.